FindTrial
Sign In

Evaluation of BCL2 and TNFa as mRNA Biomarkers for Monitoring The Immune Response in Critically ill Children

Evaluation of BCL2 and TNFa as mRNA Biomarkers for Monitoring The Immune Response in Critically ill Children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018506
Enrollment
Unknown
Registered
2018-09-21
Start date
2017-11-11
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical illness

Interventions

Case series:blood sample

Sponsors

no
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. aged 2-12 years; 2. admitted to PICU for 48 hours or more

Exclusion criteria

Exclusion criteria: end-stage renal failure, end-stage liver failure, congenital immune deficiency

Countries

egypt

Contacts

Public Contactahmed el-shazly

pediatrics - bemha university

zhraa10987@gmail.com+20 0133285314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026